Bhatt, S., Ashlock, B. M., Toomey, N. L., Diaz, L. A., Mesri, E. A., Lossos, I. S., & Ramos, J. C. (2013). Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. American Society for Clinical Investigation.

Bhatt, Shruti, Brittany M. Ashlock, Ngoc L. Toomey, Luis A. Diaz, Enrique A. Mesri, Izidore S. Lossos, und Juan Carlos Ramos. Efficacious Proteasome/HDAC Inhibitor Combination Therapy for Primary Effusion Lymphoma. American Society for Clinical Investigation, 2013.

Bhatt, Shruti, et al. Efficacious Proteasome/HDAC Inhibitor Combination Therapy for Primary Effusion Lymphoma. American Society for Clinical Investigation, 2013.